Aichi Cancer Center 10-year experience with conservative breast treatment of early breast cancer: Retrospective analysis regarding failure patterns and factors influencing local control

被引:6
作者
Kodaira, T
Fuwa, N
Itoh, Y
Matsumoto, A
Kamata, M
Furutani, K
Sasaoka, M
Miura, S
Takeuchi, T
机构
[1] Aichi Canc Ctr, Dept Therapeut Radiol, Chikusa Ku, Nagoya, Aichi 4648581, Japan
[2] Aichi Canc Ctr, Dept Breast Surg, Nagoya, Aichi 4648581, Japan
[3] Nishio Municipal Hosp, Dept Radiol, Aichi, Japan
[4] Marumo Hosp, Dept Breast Surg, Nagoya, Aichi, Japan
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2001年 / 49卷 / 05期
关键词
conservative breast therapy; local control; surgical margin; radiotherapy; multivariate analysis;
D O I
10.1016/S0360-3016(00)01576-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: We analyzed the clinical results of conservative breast therapy in our institute to determine the risk factors influencing local and distant disease recurrence. Methods and Materials: From 1989 to 1997, 301 breasts of 295 women,vith early breast cancer were treated with conservative surgery and adjuvant radiotherapy. There were 212 incidences of Stage I breast cancer, and 89 of Stage II. Patients were routinely treated with local resection, axillar dissection, and 46-50 Gy irradiation given in 23-25 fractions. Some also received a radiation boost to the tumor bed. Results: The 5-/8-year overall survival, disease-free survival, and local control rates were 93.2/91.5%, 86.0/80.6%, and 95.1/92.5%, respectively. Using both univariate and multivariate analyses, tumor volume, estrogen receptor status, and age < 40 years were significant prognostic factors for disease free survival. Both age < 40 years and surgical method had a strong effect on local control by uni- and multivariate analysis. Surgical margin status was a significant prognostic factor for local control at the univariate level (p < 0.0001), though it had only borderline significance at the multivariate level (p = 0.08). No patient experienced severe morbidity due to radiotherapy. Conclusion: The results obtained are comparable to previously reported data. Although the follow-up period was too short to draw definite conclusions about long-term outcomes, the outcome from conservative breast treatment was acceptable. <(c)> 2001 Elsevier Science Inc.
引用
收藏
页码:1311 / 1316
页数:6
相关论文
共 45 条
[1]   RISK-FACTORS IN BREAST-CONSERVATION THERAPY [J].
BORGER, J ;
KEMPERMAN, H ;
HART, A ;
PETERSE, H ;
VANDONGEN, J ;
BARTELINK, H .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :653-660
[2]   CONSERVATIVE THERAPY OF BREAST-CANCER IN QUEENSLAND [J].
BURKE, MF ;
ALLISON, R ;
OBST, D ;
TRIPCONY, L .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (02) :295-303
[3]   LOCAL-CONTROL AND SURVIVAL OF BREAST-CANCER TREATED BY LIMITED SURGERY FOLLOWED BY IRRADIATION [J].
CALLE, R ;
VILCOQ, JR ;
ZAFRANI, P ;
VIELH, P ;
FOURQUET, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (06) :873-878
[4]  
COX DR, 1972, J R STAT SOC B, V34, P187
[5]  
Dalberg K, 1998, CANCER-AM CANCER SOC, V82, P2204, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2204::AID-CNCR15>3.3.CO
[6]  
2-J
[7]  
DIBASE SJ, 1998, CANCER, V82, P2212
[8]   BREAST-CONSERVING SURGERY AND DEFINITIVE RADIATION - A COMPARISON BETWEEN QUADRANTECTOMY AND LOCAL EXCISION WITH SPECIAL FOCUS ON LOCAL-REGIONAL CONTROL AND COSMESIS [J].
FAGUNDES, MA ;
FAGUNDES, HM ;
BRITO, CS ;
FAGUNDES, MH ;
DAUDT, A ;
BRUNO, LA ;
AZEVEDO, SJ ;
FAGUNDES, LA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (03) :553-560
[9]   REANALYSIS AND RESULTS AFTER 12 YEARS OF FOLLOW-UP IN A RANDOMIZED CLINICAL-TRIAL COMPARING TOTAL MASTECTOMY WITH LUMPECTOMY WITH OR WITHOUT IRRADIATION IN THE TREATMENT OF BREAST-CANCER [J].
FISHER, B ;
ANDERSON, S ;
REDMOND, CK ;
WOLMARK, N ;
WICKERHAM, DL ;
CRONIN, WM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (22) :1456-1461
[10]   Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors [J].
Fisher, B ;
Dignam, J ;
Bryant, J ;
DeCillis, A ;
Wickerham, DL ;
Wolmark, N ;
Costantino, J ;
Redmond, C ;
Fisher, ER ;
Bowman, DM ;
Deschenes, L ;
Dimitrov, NV ;
Margolese, RG ;
Robidoux, A ;
Shibata, H ;
Terz, J ;
Paterson, AHG ;
Feldman, MI ;
Farrar, W ;
Evans, J ;
Lickley, HL .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (21) :1529-1542